AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Chief Executive Officer Pascal Soriot buys 20,000 shares at GBP102.03, worth GBP2.0 million, on Thursday.

AstraZeneca has allocated $3.5billion to expand its US manufacturing and research footprint by the end of 2026. The funding ...

Cambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company ...